Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands

Rajinder S. Sawhney, Guo Hao K Zhou, Lisa E. Humphrey, Paramita M Ghosh, Jeffrey I. Kreisberg, Michael G. Brattain

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Despite constitutive expression of autocrine transforming growth factor-α (TGF-α) in growth factor-independent colon carcinoma cells, the epidermal growth factor receptor (EGFr) is not saturated and can be further activated by exogenous EGFr ligand. Given that the activation of EGFr by exogenous growth factor has no further effect on DNA synthesis, the question arises as to what function this additional EGFr activation might have. We report that EGF induces integrin α2 expression, integrin-mediated adhesion, and micromotility of HCT116 cells. The stimulatory effect of ligand on these biological functions is abrogated by treatment with AG1478- and EGFr-blocking monoclonal antibody. This provides evidence that the biological responses are EGFr-mediated and EGFr is located upstream of integrin α2 expression. Therefore, although exogenous EGF has no effect on DNA synthesis beyond that induced by autocrine TGF-α (at subsaturating levels of EGFr occupation) exogenous growth factor does induce integrin α2 expression, cell adhesion, and micromotion. An important finding revealed by this study is the documentation of biological responses of EGFr-mediated functions, including DNA synthesis, cell adhesion, and micromotion, which differ in sensitivity with respect to different degrees of EGFr activation at the basal state and in response to exogenous ligand.

Original languageEnglish (US)
Pages (from-to)75-86
Number of pages12
JournalJournal of Biological Chemistry
Volume277
Issue number1
DOIs
StatePublished - Jan 4 2002
Externally publishedYes

Fingerprint

Epidermal Growth Factor Receptor
Chemical activation
Ligands
Integrins
Intercellular Signaling Peptides and Proteins
Cell adhesion
Transforming Growth Factors
Epidermal Growth Factor
Cell Adhesion
DNA
HCT116 Cells
Blocking Antibodies
Occupations
Documentation
Colon
Adhesion
Monoclonal Antibodies
Cells
Carcinoma

ASJC Scopus subject areas

  • Biochemistry

Cite this

Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands. / Sawhney, Rajinder S.; Zhou, Guo Hao K; Humphrey, Lisa E.; Ghosh, Paramita M; Kreisberg, Jeffrey I.; Brattain, Michael G.

In: Journal of Biological Chemistry, Vol. 277, No. 1, 04.01.2002, p. 75-86.

Research output: Contribution to journalArticle

Sawhney, Rajinder S. ; Zhou, Guo Hao K ; Humphrey, Lisa E. ; Ghosh, Paramita M ; Kreisberg, Jeffrey I. ; Brattain, Michael G. / Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands. In: Journal of Biological Chemistry. 2002 ; Vol. 277, No. 1. pp. 75-86.
@article{cf60c72f6e894bd5856bc75e61acb34b,
title = "Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands",
abstract = "Despite constitutive expression of autocrine transforming growth factor-α (TGF-α) in growth factor-independent colon carcinoma cells, the epidermal growth factor receptor (EGFr) is not saturated and can be further activated by exogenous EGFr ligand. Given that the activation of EGFr by exogenous growth factor has no further effect on DNA synthesis, the question arises as to what function this additional EGFr activation might have. We report that EGF induces integrin α2 expression, integrin-mediated adhesion, and micromotility of HCT116 cells. The stimulatory effect of ligand on these biological functions is abrogated by treatment with AG1478- and EGFr-blocking monoclonal antibody. This provides evidence that the biological responses are EGFr-mediated and EGFr is located upstream of integrin α2 expression. Therefore, although exogenous EGF has no effect on DNA synthesis beyond that induced by autocrine TGF-α (at subsaturating levels of EGFr occupation) exogenous growth factor does induce integrin α2 expression, cell adhesion, and micromotion. An important finding revealed by this study is the documentation of biological responses of EGFr-mediated functions, including DNA synthesis, cell adhesion, and micromotion, which differ in sensitivity with respect to different degrees of EGFr activation at the basal state and in response to exogenous ligand.",
author = "Sawhney, {Rajinder S.} and Zhou, {Guo Hao K} and Humphrey, {Lisa E.} and Ghosh, {Paramita M} and Kreisberg, {Jeffrey I.} and Brattain, {Michael G.}",
year = "2002",
month = "1",
day = "4",
doi = "10.1074/jbc.M103268200",
language = "English (US)",
volume = "277",
pages = "75--86",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "1",

}

TY - JOUR

T1 - Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands

AU - Sawhney, Rajinder S.

AU - Zhou, Guo Hao K

AU - Humphrey, Lisa E.

AU - Ghosh, Paramita M

AU - Kreisberg, Jeffrey I.

AU - Brattain, Michael G.

PY - 2002/1/4

Y1 - 2002/1/4

N2 - Despite constitutive expression of autocrine transforming growth factor-α (TGF-α) in growth factor-independent colon carcinoma cells, the epidermal growth factor receptor (EGFr) is not saturated and can be further activated by exogenous EGFr ligand. Given that the activation of EGFr by exogenous growth factor has no further effect on DNA synthesis, the question arises as to what function this additional EGFr activation might have. We report that EGF induces integrin α2 expression, integrin-mediated adhesion, and micromotility of HCT116 cells. The stimulatory effect of ligand on these biological functions is abrogated by treatment with AG1478- and EGFr-blocking monoclonal antibody. This provides evidence that the biological responses are EGFr-mediated and EGFr is located upstream of integrin α2 expression. Therefore, although exogenous EGF has no effect on DNA synthesis beyond that induced by autocrine TGF-α (at subsaturating levels of EGFr occupation) exogenous growth factor does induce integrin α2 expression, cell adhesion, and micromotion. An important finding revealed by this study is the documentation of biological responses of EGFr-mediated functions, including DNA synthesis, cell adhesion, and micromotion, which differ in sensitivity with respect to different degrees of EGFr activation at the basal state and in response to exogenous ligand.

AB - Despite constitutive expression of autocrine transforming growth factor-α (TGF-α) in growth factor-independent colon carcinoma cells, the epidermal growth factor receptor (EGFr) is not saturated and can be further activated by exogenous EGFr ligand. Given that the activation of EGFr by exogenous growth factor has no further effect on DNA synthesis, the question arises as to what function this additional EGFr activation might have. We report that EGF induces integrin α2 expression, integrin-mediated adhesion, and micromotility of HCT116 cells. The stimulatory effect of ligand on these biological functions is abrogated by treatment with AG1478- and EGFr-blocking monoclonal antibody. This provides evidence that the biological responses are EGFr-mediated and EGFr is located upstream of integrin α2 expression. Therefore, although exogenous EGF has no effect on DNA synthesis beyond that induced by autocrine TGF-α (at subsaturating levels of EGFr occupation) exogenous growth factor does induce integrin α2 expression, cell adhesion, and micromotion. An important finding revealed by this study is the documentation of biological responses of EGFr-mediated functions, including DNA synthesis, cell adhesion, and micromotion, which differ in sensitivity with respect to different degrees of EGFr activation at the basal state and in response to exogenous ligand.

UR - http://www.scopus.com/inward/record.url?scp=0037016733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037016733&partnerID=8YFLogxK

U2 - 10.1074/jbc.M103268200

DO - 10.1074/jbc.M103268200

M3 - Article

C2 - 11684674

AN - SCOPUS:0037016733

VL - 277

SP - 75

EP - 86

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 1

ER -